Limiting Iron Supplementation for Anemia in Dialysis Patients-The Basis for Japan's Conservative Guidelines

Seminars in Dialysis

Volumn 24, Issue 3, 2011, Pages 269-271

  Yamamoto, Hiroyasu ^a   Tsubakihara, Yoshiharu ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; CYTOKINE; FERRITIN; HEPCIDIN; IRON; METAL TRANSPORTING PROTEIN 1;

ANEMIA; BLOOD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; DOSE RESPONSE; EDITORIAL; HUMAN; IRON OVERLOAD; METABOLISM; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY;

ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CYTOKINES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITINS; HUMANS; IRON; IRON OVERLOAD; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS;

EID: 79959327635     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00938.x     Document Type: Editorial

References (22)

1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and phase II clinical trial. N Engl J Med 316:73-78, 1987
2. K/DOQI: K/DOQI clinical practice guidelines and clinical recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47(Suppl. 3):S9-S145, 2006
3. Anonymous: Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19(Suppl. 2):ii-ii47, 2004
4. Japanese Society for Dialysis Therapy: Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial 14(3):240-275, 2008
5. Aisen P, Enns C, Wessling-Resnick M: Chemistry and biology of eukaryotic iron metabolism. Int J Biochem Cell Biol 33:940-959, 2001
6. Gomme PT, McCann KB, Bertolini J: Transferrin: structure, function and potential therapeutic actions. Drug Discov Today 10:267-273, 2005
7. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI: Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670-2677, 2003
8. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J: Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88:7-15, 2008
9. Pollycove M, Maqsood M: Existence of an erythropoietic labile iron pool in animals. Nature 194:152-154, 1962
10. Ferrari P, Kulkarni H, Dheda S, Betti S, Harrison C, St Pierre TG, Olynyk JK: Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. Clin J Am Soc Nephrol 6:77-83, 2011
11. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275(26):19906-19912, 2000
12. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810, 2001
13. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093, 2004
14. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276, 2004
15. Lee P, Peng H, Gelbart T, Wang L, Beutler E: Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 102:1906-1910, 2005
16. Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y: Importance of ferritin for optimizing anemia therapy in chronic kidney disease. Am J Nephrol 32:439-446, 2010
17. Otaki Y, Nakanishi T, Hasuike Y, Moriguchi R, Nanami M, Hama Y, Izumi M, Takamitsu Y: Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis. Am J Kidney Dis 43:1030-1039, 2004
18. Cavill I: Iron status as measured by serum ferritin: the marker and its limitations. Am J Kidney Dis 34:S12-S17, 1999
19. The Japan Bioiron Society, ed. Guidelines for the Prevention and Treatment of Iron Deficiency and Iron Deficiency Anemia, 1st edn. Sapporo: Kyobunsha, 2004
20. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G: Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113:5277-5286, 2009
21. Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A, Witteman JC: Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 69(6):1231-1236, 1999
22. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96(10):3300-3307, 1997